Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Cardiol ; 22(3): 233-5, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10084069

ABSTRACT

Although unusual in the older patient, coarctation of the aorta can be an occult cause of cardiomyopathy. This report describes a 53-year-old man with new-onset heart failure symptoms, global left ventricular (LV) dysfunction, and underlying aortic coarctation. Surgical correction resulted in reduced LV size, resolution of symptoms, and normalization of atrial natriuretic hormone levels.


Subject(s)
Aortic Coarctation/surgery , Atrial Natriuretic Factor/blood , Heart Ventricles/pathology , Aortic Coarctation/blood , Aortic Coarctation/complications , Cardiomyopathy, Dilated/etiology , Cardiomyopathy, Dilated/pathology , Humans , Male , Middle Aged
2.
Circulation ; 89(4): 1760-8, 1994 Apr.
Article in English | MEDLINE | ID: mdl-7511993

ABSTRACT

BACKGROUND: Cell adhesion molecules (CAMs) have been implicated in cardiac allograft rejection. However, previous studies have used qualitative analysis of immunohistochemical data and did not exclude patients with infection or malignancy. METHODS AND RESULTS: We analyzed 40 endomyocardial biopsy specimens from 25 cardiac transplant patients and 8 specimens from patients undergoing cardiac surgery. Patients with evidence of infection or malignancy were excluded. Specimens were stained with monoclonal antibodies against ICAM-1, E-selectin, VCAM-1, and PECAM-1 (which labels all vessels). ICAM-1 expression was assessed by counting ICAM-1-positive vessels and dividing by the total number of vessels (measured by PECAM staining). Specimens were scored as positive or negative for VCAM-1 and E-selectin. We also determined whether serum-soluble ICAM-1 levels (sICAM) correlated with rejection by evaluating 145 serum specimens from 48 cardiac transplant patients and 8 specimens from patients undergoing diagnostic cardiac catheterization. ICAM-1 was present on 50% to 60% of vessels in normal and nonrejecting specimens. Specimens with histologically significant rejection (focal moderate, moderate, or severe) had an increased percentage of ICAM-1-positive vessels: focal moderate, 77%; moderate/severe, 92% (P < .01). E-selectin expression did not differ between groups. VCAM-1 frequently was not present on rejecting specimens. No correlation was noted between sICAM levels and the presence or absence of rejection. CONCLUSIONS: (1) ICAM-1 expression is strongly correlated with histologically significant cardiac allograft rejection. (2) The use of PECAM-1 staining as a vascular marker permits quantitative analysis of ICAM-1 expression. (3) VCAM-1 and E-selectin are not consistently increased during cardiac allograft rejection. (4) sICAM levels do not accurately reflect endomyocardial biopsy results.


Subject(s)
Cell Adhesion Molecules/metabolism , Graft Rejection/diagnosis , Heart Transplantation/pathology , Myocardium/metabolism , Antigens, CD/metabolism , Biopsy , Cell Adhesion , E-Selectin , Heart Transplantation/immunology , Humans , Intercellular Adhesion Molecule-1 , Middle Aged , Myocardium/pathology , Vascular Cell Adhesion Molecule-1
SELECTION OF CITATIONS
SEARCH DETAIL
...